Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 52

1.

Issues in women's participation in a phase III community HIV vaccine trial in Thailand.

Kaewkungwal J, Pitisuttithum P, Rerks-Ngarm S, Nitayaphan S, Khamboonruang C, Kunasol P, Suntharasamai P, Pungpak S, Vanijanonta S, Bussaratid V, Maek-A-Nantawat W, Dhitavat J, Thongcharoen P, Pawarana R, Sabmee Y, Benenson MW, Morgan P, O'Connell RJ, Kim J.

AIDS Res Hum Retroviruses. 2013 Nov;29(11):1524-34. doi: 10.1089/AID.2012.0265. Epub 2013 Feb 25.

2.

The Thai phase III trial (RV144) vaccine regimen induces T cell responses that preferentially target epitopes within the V2 region of HIV-1 envelope.

de Souza MS, Ratto-Kim S, Chuenarom W, Schuetz A, Chantakulkij S, Nuntapinit B, Valencia-Micolta A, Thelian D, Nitayaphan S, Pitisuttithum P, Paris RM, Kaewkungwal J, Michael NL, Rerks-Ngarm S, Mathieson B, Marovich M, Currier JR, Kim JH; Ministry of Public Health–Thai AIDS Vaccine Evaluation Group Collaborators.

J Immunol. 2012 May 15;188(10):5166-76. doi: 10.4049/jimmunol.1102756. Epub 2012 Apr 23.

3.

Safety and reactogenicity of canarypox ALVAC-HIV (vCP1521) and HIV-1 gp120 AIDSVAX B/E vaccination in an efficacy trial in Thailand.

Pitisuttithum P, Rerks-Ngarm S, Bussaratid V, Dhitavat J, Maekanantawat W, Pungpak S, Suntharasamai P, Vanijanonta S, Nitayapan S, Kaewkungwal J, Benenson M, Morgan P, O'Connell RJ, Berenberg J, Gurunathan S, Francis DP, Paris R, Chiu J, Stablein D, Michael NL, Excler JL, Robb ML, Kim JH.

PLoS One. 2011;6(12):e27837. doi: 10.1371/journal.pone.0027837. Epub 2011 Dec 21.

4.

Screening and evaluation of potential volunteers for a phase III trial in Thailand of a candidate preventive HIV vaccine (RV148).

Ministry of Public Health-Thai AIDS Vaccine Evaluation Group.

Vaccine. 2011 Jun 6;29(25):4285-92. doi: 10.1016/j.vaccine.2011.03.014. Epub 2011 Mar 22.

PMID:
21435408
5.

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.

Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, Premsri N, Namwat C, de Souza M, Adams E, Benenson M, Gurunathan S, Tartaglia J, McNeil JG, Francis DP, Stablein D, Birx DL, Chunsuttiwat S, Khamboonruang C, Thongcharoen P, Robb ML, Michael NL, Kunasol P, Kim JH; MOPH-TAVEG Investigators.

N Engl J Med. 2009 Dec 3;361(23):2209-20. doi: 10.1056/NEJMoa0908492. Epub 2009 Oct 20.

6.

Cysticercosis: IgG-ELISA evaluations of peak1 antigen and <30 kDa antigen of delipidized extract of Taenia solium metacestodes.

Dekumyoy P, Waikagul J, Vanijanonta S, Thairungroj M, Nakao M, Sako Y, Watanabe S, Ito A.

Southeast Asian J Trop Med Public Health. 2004 Mar;35(1):1-9.

PMID:
15272737
7.

Studies of the neurotoxicity of oral artemisinin derivatives in mice.

Nontprasert A, Pukrittayakamee S, Nosten-Bertrand M, Vanijanonta S, White NJ.

Am J Trop Med Hyg. 2000 Mar;62(3):409-12.

PMID:
11037787
8.

Therapeutic responses to quinine and clindamycin in multidrug-resistant falciparum malaria.

Pukrittayakamee S, Chantra A, Vanijanonta S, Clemens R, Looareesuwan S, White NJ.

Antimicrob Agents Chemother. 2000 Sep;44(9):2395-8.

9.

Therapeutic responses to different antimalarial drugs in vivax malaria.

Pukrittayakamee S, Chantra A, Simpson JA, Vanijanonta S, Clemens R, Looareesuwan S, White NJ.

Antimicrob Agents Chemother. 2000 Jun;44(6):1680-5.

10.

Use of delipidized antigens of Taenia solium metacestodes in IgG-ELISA for detection of neurocysticercosis.

Dekumyoy P, Vanijanonta S, Waikagul J, Sa-nguankiat S, Danis M.

Southeast Asian J Trop Med Public Health. 1998 Sep;29(3):572-8.

PMID:
10437960
11.

Pulmonary oedema in vivax malaria.

Pukrittayakamee S, Chantra A, Vanijanonta S, White NJ.

Trans R Soc Trop Med Hyg. 1998 Jul-Aug;92(4):421-2. No abstract available.

PMID:
9850397
12.

Assessment of the neurotoxicity of parenteral artemisinin derivatives in mice.

Nontprasert A, Nosten-Bertrand M, Pukrittayakamee S, Vanijanonta S, Angus BJ, White NJ.

Am J Trop Med Hyg. 1998 Oct;59(4):519-22.

PMID:
9790421
13.

Monotherapy with sodium artesunate for uncomplicated falciparum malaria in Thailand: a comparison of 5- and 7-day regimens.

Looareesuwan S, Wilairatana P, Vanijanonta S, Pitisuttithum P, Ratanapong Y, Andrial M.

Acta Trop. 1997 Sep 30;67(3):197-205.

PMID:
9241384
14.

Open randomized trial of oral artemether alone and a sequential combination with mefloquine for acute uncomplicated falciparum malaria.

Looareesuwan S, Wilairatana P, Viravan C, Vanijanonta S, Pitisuttithum P, Kyle DE.

Am J Trop Med Hyg. 1997 Jun;56(6):613-7.

PMID:
9230790
15.

Disposition of proguanil in Thai patients with uncomplicated falciparum malaria.

Edstein MD, Looareesuwan S, Wilairatana P, Vanijanonta S, Kyle DE, Rieckmann KH.

Am J Trop Med Hyg. 1997 May;56(5):498-502.

PMID:
9180597
16.

Plasma macrophage colony-stimulating factor and P-selectin levels in malaria-associated thrombocytopenia.

Lee SH, Looareesuwan S, Chan J, Wilairatana P, Vanijanonta S, Chong SM, Chong BH.

Thromb Haemost. 1997 Feb;77(2):289-93.

PMID:
9157583
17.

Antimalarial activity and interactions between quinine, dihydroquinine and 3-hydroxyquinine against Plasmodium falciparum in vitro.

Nontprasert A, Pukrittayakamee S, Kyle DE, Vanijanonta S, White NJ.

Trans R Soc Trop Med Hyg. 1996 Sep-Oct;90(5):553-5.

PMID:
8944272
18.

Serum laminin and basic fibroblast growth factor concentrations in patients with complicated Plasmodium falciparum malaria.

Burgmann H, Looareesuwan S, Viravan C, Vanijanonta S, Zedwitz-Liebenstein K, Vorbach H, Graninger W.

J Clin Immunol. 1996 Sep;16(5):278-82.

PMID:
8886997
19.

Elevated levels of soluble CD14 in serum of patients with acute Plasmodium falciparum malaria.

Wenisch C, Wenisch H, Parschalk B, Vanijanonta S, Burgmann H, Exner M, Zedwitz-Liebenstein K, Thalhammer F, Georgopoulos A, Graninger W, Looareesuwan S.

Clin Exp Immunol. 1996 Jul;105(1):74-8.

20.

Therapeutic effects of chloroquine in combination with quinine in uncomplicated falciparum malaria.

Vanijanonta S, Chantra A, Phophak N, Chindanond D, Clemens R, Pukrittayakamee S.

Ann Trop Med Parasitol. 1996 Jun;90(3):269-75.

PMID:
8758141

Supplemental Content

Loading ...
Support Center